Skip to main content
logo
HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
12.48
-0.16 (-1.27%)
Aug 19, 2026, 2:01 PM EDT - Market open

HUTCHMED (China) Revenue

HUTCHMED (China) had revenue of $278.29M in the half year ending June 30, 2026, a decrease of -8.96%. This brings the company's revenue in the last twelve months to $549.12M, down -8.81% year-over-year. In the year 2025, HUTCHMED (China) had annual revenue of $548.51M, down -12.96%.

Revenue (ttm)
$549.12M
Revenue Growth
-8.81%
P/S Ratio
4.05
Revenue / Employee
$306,772
Employees
1,790
Market Cap
2.22B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025548.51M-81.69M-12.96%
Dec 31, 2024630.20M-207.80M-24.80%
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020227.98M23.09M11.27%
Dec 31, 2019204.89M-9.22M-4.31%
Dec 31, 2018214.11M-27.09M-11.23%
Dec 31, 2017241.20M25.12M11.63%
Dec 31, 2016216.08M37.88M21.25%
Dec 31, 2015178.20M90.87M104.06%
Dec 31, 201487.33M--
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bausch Health Companies10.85B
Perrigo Company4.14B
Trulieve Cannabis1.14B
Prestige Consumer Healthcare1.10B
ANI Pharmaceuticals978.38M
BioCryst Pharmaceuticals940.61M
Supernus Pharmaceuticals830.44M
Xeris Biopharma Holdings335.41M
Revenue Rankings

HCM News

More News